ABUS vs. ARMP

Last updated Jun 3, 2026

ABUS (Arbutus Biopharma Corporation) and ARMP (Armata Pharmaceuticals Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, ABUS returned 0.76%/yr vs -30.20%/yr for ARMP. At a 0.06 correlation, their price movements are largely independent.

Performance

ABUS vs. ARMP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arbutus Biopharma Corporation (ABUS) and Armata Pharmaceuticals Inc. (ARMP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ABUS achieves a -11.43% return, which is significantly lower than ARMP's 26.11% return. Over the past 10 years, ABUS has outperformed ARMP with an annualized return of 0.76%, while ARMP has yielded a comparatively lower -30.20% annualized return.

ABUS

• 1D: -4.91%
• 1M: -1.39%
• YTD: -11.43%
• 6M: 2.16%
• 1Y: 26.79%
• 3Y*: 18.19%
• 5Y*: 7.63%
• 10Y*: 0.76%

ARMP

• 1D: 1.54%
• 1M: -10.91%
• YTD: 26.11%
• 6M: 49.15%
• 1Y: 308.25%
• 3Y*: 70.07%
• 5Y*: 13.80%
• 10Y*: -30.20%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ABUS vs. ARMP - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ABUS Arbutus Biopharma Corporation	-11.43%	47.09%	30.80%	7.30%	-40.10%	9.58%	27.70%	-27.42%	-24.16%	106.12%
ARMP Armata Pharmaceuticals Inc.	26.11%	239.46%	-42.90%	161.29%	-77.37%	83.59%	-8.16%	12.53%	-79.57%	-77.05%

Correlation

The correlation between ABUS and ARMP is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.06
Correlation (10Y) Calculated over the trailing 10-year period	0.05
Correlation (All Time) Calculated using the full available price history since Aug 4, 2015	0.06

Fundamentals

Market Cap ABUS : $831.61M ARMP : $289.32M
EPS ABUS : $0.83 ARMP : -$7.79
PS Ratio ABUS : 4.29 ARMP : 65.14
Total Revenue (TTM) ABUS : $191.45M ARMP : $4.41M
Gross Profit (TTM) ABUS : $12.30M ARMP : $3.26M
EBITDA (TTM) ABUS : $156.13M ARMP : -$27.14M

Return for Risk

ABUS vs. ARMP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABUS

ABUS Risk / Return Rank: 59
ABUS Sharpe Ratio Rank: 60
ABUS Sortino Ratio Rank: 55
ABUS Omega Ratio Rank: 53
ABUS Calmar Ratio Rank: 62
ABUS Martin Ratio Rank: 64

ARMP

ARMP Risk / Return Rank: 92
ARMP Sharpe Ratio Rank: 89
ARMP Sortino Ratio Rank: 92
ARMP Omega Ratio Rank: 90
ARMP Calmar Ratio Rank: 93
ARMP Martin Ratio Rank: 94

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ABUS vs. ARMP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Arbutus Biopharma Corporation (ABUS) and Armata Pharmaceuticals Inc. (ARMP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ABUS	ARMP	Difference
Sharpe ratio Return per unit of total volatility	0.58	2.20	-1.61
Sortino ratio Return per unit of downside risk	1.07	3.65	-2.58
Omega ratio Gain probability vs. loss probability	1.13	1.45	-0.31
Calmar ratio Return relative to maximum drawdown	1.04	6.29	-5.26
Martin ratio Return relative to average drawdown	2.62	17.21	-14.59
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ABUS vs. ARMP - Sharpe Ratio Comparison

The current ABUS Sharpe Ratio is 0.58, which is lower than the ARMP Sharpe Ratio of 2.20. The chart below compares the historical Sharpe Ratios of ABUS and ARMP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ABUS	ARMP	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.58	2.20	-1.61
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.14	0.12	+0.02
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.01	-0.27	+0.28
Sharpe Ratio (All Time) Calculated using the full available price history	-0.10	-0.24	+0.14

Drawdowns

ABUS vs. ARMP - Drawdown Comparison

The maximum ABUS drawdown since its inception was -92.96%, smaller than the maximum ARMP drawdown of -99.98%. Use the drawdown chart below to compare losses from any high point for ABUS and ARMP.

Drawdown Indicators

	ABUS	ARMP	Difference
Max Drawdown Largest peak-to-trough decline	-92.96%	-99.98%	+7.02%
Max Drawdown (1Y) Largest decline over 1 year	-25.86%	-48.65%	+22.79%
Max Drawdown (3Y) Largest decline over 3 years	-36.84%	-79.22%	+42.38%
Max Drawdown (5Y) Largest decline over 5 years	-63.42%	-85.70%	+22.28%
Max Drawdown (10Y) Largest decline over 10 years	-92.96%	-99.69%	+6.73%
Current Drawdown Current decline from peak	-65.51%	-99.84%	+34.33%
Average Drawdown Average peak-to-trough decline	-68.77%	-82.78%	+14.01%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.21%	17.79%	-7.58%

Volatility

ABUS vs. ARMP - Volatility Comparison

The current volatility for Arbutus Biopharma Corporation (ABUS) is 10.98%, while Armata Pharmaceuticals Inc. (ARMP) has a volatility of 23.84%. This indicates that ABUS experiences smaller price fluctuations and is considered to be less risky than ARMP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ABUS	ARMP	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.98%	23.84%	-12.86%
Volatility (6M) Calculated over the trailing 6-month period	36.23%	80.43%	-44.20%
Volatility (1Y) Calculated over the trailing 1-year period	46.04%	141.42%	-95.38%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	54.93%	113.73%	-58.80%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	85.54%	110.47%	-24.93%

Dividends

ABUS vs. ARMP - Dividend Comparison

Neither ABUS nor ARMP has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ABUS and ARMP in my portfolio?

ABUS and ARMP have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ABUS or ARMP?

ARMP has higher volatility (23.84%) compared to ABUS (10.98%). In terms of maximum drawdown, ABUS dropped -92.96% vs ARMP's -99.98%.

Which has better risk-adjusted returns?

ARMP currently has the higher Sharpe Ratio (2.20 vs 0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.